GE Healthcare Technologies Inc
NASDAQ:GEHC

Watchlist Manager
GE Healthcare Technologies Inc Logo
GE Healthcare Technologies Inc
NASDAQ:GEHC
Watchlist
Price: 79.06 USD -0.28% Market Closed
Market Cap: 36.1B USD
Have any thoughts about
GE Healthcare Technologies Inc?
Write Note

Net Margin
GE Healthcare Technologies Inc

8.6%
Current
9%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.6%
=
Net Income
1.7B
/
Revenue
19.6B

Net Margin Across Competitors

Country US
Market Cap 36.1B USD
Net Margin
9%
Country US
Market Cap 199B USD
Net Margin
14%
Country US
Market Cap 191.3B USD
Net Margin
29%
Country US
Market Cap 141.3B USD
Net Margin
16%
Country US
Market Cap 134.2B USD
Net Margin
11%
Country IE
Market Cap 104.6B USD
Net Margin
13%
Country US
Market Cap 65.6B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.5B USD
Net Margin
74%
Country CN
Market Cap 311.1B CNY
Net Margin
33%
Country US
Market Cap 34.1B USD
Net Margin
23%
No Stocks Found

GE Healthcare Technologies Inc
Glance View

Market Cap
36.1B USD
Industry
Health Care

GE Healthcare Technologies Inc. operates as a pivotal player in the vast landscape of medical technology, skillfully weaving a narrative that integrates cutting-edge innovation with practical application. As a segment originally spun out from the iconic General Electric Company, GE Healthcare focuses on enhancing diagnostics and patient care through its advanced imaging and monitoring systems. The company's portfolio spans a wide range of products, including magnetic resonance imaging (MRI) machines, ultrasound devices, and computed tomography (CT) scanners, each designed to provide medical professionals with critical insights needed for accurate diagnosis and effective treatment. By leveraging decades of engineering expertise and a rich history in innovation, GE Healthcare not only improves hospital efficiencies but also supports personalized healthcare solutions that help in the early detection and effective management of diseases. Their revenue model is primarily centered around the sale of these high-technology machines and the accompanying service agreements that ensure their seamless operation. Additionally, the company generates income from its work in life sciences, offering a suite of applications and software that assist in drug discovery and bioprocessing. Combining hardware sales with recurring revenue streams from maintenance services and digital solutions enhances the company’s financial stability. This multifaceted approach positions GE Healthcare as both a stalwart in existing medical technology fields and a pioneer exploring the frontiers of healthcare innovations, driven by a mission to improve patient outcomes worldwide.

GEHC Intrinsic Value
90.06 USD
Undervaluation 12%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.6%
=
Net Income
1.7B
/
Revenue
19.6B
What is the Net Margin of GE Healthcare Technologies Inc?

Based on GE Healthcare Technologies Inc's most recent financial statements, the company has Net Margin of 8.6%.